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Sunday, February 26, 2012 19aenhance the intrinsic ability of membranes to promote lateral organization of
lipidated proteins in highly curved areas.
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Molecular Simulations of the Membrane-Associated State of the PTEN
Tumour-Suppressor Protein
Craig N. Lumb, Mark S.P. Sansom.
University of Oxford, Oxford, United Kingdom.
PTEN is a tumour-suppressor protein responsible for regulating the phosphati-
dylinositol 3-kinase (PI3K) signalling pathway. The action of PI3K generates
PI(3,4,5)P3, which goes on to promote several downstream processes such as
cell proliferation and survival through its ability to recruit protein kinase B
or Akt (PKB/Akt) and other proteins containing pleckstrin homology (PH)
domains to the cytoplasmic leaflet of the plasma membrane. Negative regula-
tion of PI3K signalling by PTEN is achieved through degradation of PI(3,4,5)
P3 to PI(4,5)P2 by hydrolysis of the D3 phosphate, thereby controlling the
plasma membrane concentration of PI(3,4,5)P3. However, inactivating muta-
tions of PTEN that impair its lipid phosphatase activity can result in accumu-
lation of PI(3,4,5)P3 and lead to uncontrolled downstream PI3K signalling and
subsequent tumourigenesis. PTEN possesses a two-domain architecture, with
a phosphatase domain responsible for PI(3,4,5)P3 hydrolysis and a C2 domain.
In an effort to better understand the nature of the membrane-associated state of
PTEN, we used molecular modelling to generate a model of the protein-
membrane complex based on the crystal structure of cytosolic PTEN (PDB
1D5R) and explored its interactions with PI(3,4,5)P3 and the surrounding mem-
brane lipids using molecular dynamics simulations at both coarse-grained and
atomistic resolution. The predicted location of the protein/membrane interface
was robust to changes in both resolution of the simulations and in bilayer lipid
composition. We identified several key membrane-interacting amino acid
residues lining this interface, some of which correspond to the locations of
established disease-causing mutations, and demonstrated that mutation of these
residues in silico can reduce the degree of membrane interaction.
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Gerald Stu¨biger1, Heinrich J. Matthies2, Aurelio Galli2, Gerhard F. Ecker3,
Valery Bochkov1, Stefan Boehm1, Florian Buchmayer1.
1Medical University Vienna, Vienna, Austria, 2Vanderbilt University,
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Neuronal functions, such as excitability or endo- and exocytosis, require
phosphatidylinositol-4,5-bisphosphate (PIP2) since ion channels and other pro-
teins involved in these processes are regulated by PIP2. Monoamine trans-
porters control neurotransmission by removing monoamines from the
extracellular space. They also display channel properties, but their regulation
by PIP2 has not been reported. The psychostimulant amphetamine acts on
monoamine transporters to stimulate transporter-mediated currents and efflux
and thereby increases the levels of extracellular monoamines. Direct or
receptor-mediated activation of phospholipase-C (PLC) reduced membrane
PIP2 and amphetamine-evoked currents through recombinant serotonin trans-
porters; extracellular application of a PIP2-scavenging peptide mimicked this
effect. PLC activation also diminished amphetamine-induced reverse transport
without altering transmitter uptake. Inhibition of reverse transport by PLC ac-
tivation was also observed in brain slices and with recombinant dopamine and
noradrenaline, but not GABA transporters; rises in intracellular Ca2þ or acti-
vation of protein kinase C were not involved in these effects. These data dem-
onstrate for the first time PIP2-dependence of reverse transport and current in
monoamine transporters.
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CRTD, Dresden, Germany.
The neuronal membrane protein neuroligin-1 (Nlg-1) is best known for its in-
teraction with neurexin, and its ability to trigger presynaptic differentiation in
a neurexin-expressing axon. Here, we are reporting that nlg-1 over-expression
in developing neurons triggers extensive morphology changes. We show thatsimilar changes are observed in HEK-293 cells when we co-expressed nlg-1
with psd-95, a scaffolding protein which binds nlg-1 PDZ domain. Co-
transfected cells exhibited long expansions resembling dendritic branches, as
well as a significant increase in cell surface area. These branches could be
destabilized by adding a PI3K inhibitor, or by depleting the membrane choles-
terol suggesting that the formation of these branches is due to membrane lipid
domain formation around nlg-1 clusters. We have exploited the photophysical
properties of cerulean, a fluorescent protein, to assess environment and confor-
mational changes in nlg-1. Fluorescence lifetime anisotropy imaging showed
that neuroligin-cerulean fusion protein environment is not uniform along these
branches, and that broad changes in life time anisotropy are observed upon
addition of PI3K inhibitor. These measurements suggest that neuroligin tight
clustering is involved in changing cell membrane phosphoinositol lipid compo-
sition enabling the recruitment of PI3K, which in turns promotes the growth
and the maintenance of these expansions.
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T cell activation begins with the formation of signaling complexes at the cell
surface involving among others, the T cell antigen receptor (TCR), the Src fam-
ily kinase Lck and the adaptor protein, linker for activation of T cells (LAT).
We have established photo-activatable localization microscopy (PALM), sto-
chastic optical reconstruction microscopy (STORM), dual channel PALM/di-
rect STORM (dSTORM), live cell PALM and quantitative statistical cluster
analysis to determine how TCR engagement reorganizes the T cell membrane
on the molecular scale.
In quiescent T cells, LAT is already segregated into clusters on the cell surface
raising the question how TCR triggering initiates signaling through these pre-
existing domains. We demonstrated that pre-existing LAT domains are neither
phosphorylated nor laterally transported to the TCR activation site suggesting
that these clusters do not participate in TCR signaling. Instead, TCR activation
results in the recruitment, and phosphorylation of new LAT clusters from sub-
synaptic vesicles. Our data suggests that TCR ligation preconditions the mem-
brane for vesicle recruitment and bulk activation of the LAT signaling network.
We next demonstrated that TCR triggering re-organizes Lck into distinct sig-
naling clusters. Lck clustering, driven by self-association was independent of
the kinase activation state but TCR activation segregated Lck clusters from
clusters of the phosphatase CD45. In addition, de-phosphorylation of Lck,
either at Tyr 394 or Tyr 505, resulted in larger but fewer clusters. Phosphory-
lated TCR and Lck co-clustered at the centre of the activation area suggesting
that molecular re-organization may result in unique TCR signaling domains in
the plasma membrane.
In conclusion, single-molecule imaging provides insights into T cell signaling
that could not have been obtained by any other means.
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Using FCS to Study Protein Disorder and Aggregation
Elizabeth Rhoades, Ph.D.
Molecular Biophysics & Biochemistry Department, Yale University,
New Haven, CT, USA.
Fluorescence correlation spectroscopy (FCS) is powerful approach for studying
the dynamic properties of fluorescently labeled biomolecules including diffu-
sion, binding, and conformational dynamics. We have applied FCS to the study
of membrane binding, dynamics, and aggregation of two intrinsically disor-
dered proteins. The first, a-synuclein, is a small, neuronal proteins whose
aggregation is implicated in Parkinson’s disease. Its native functions are poorly
understood, but are thought to involve binding to cellular membranes. Here we
have measured the free energy of binding of a-Synuclein to lipid membranes
using FCS. Our results show that the binding energy can be strongly altered
by changes to the bilayer curvature and composition, suggesting that even mod-
est changes to lipid components in vivo may be able to exert significant effects
on a-Synuclein function. Furthermore, modifications to the C-terminus of
a-Synuclein, which does not directly interact with the lipid bilayer but exerts
control of the aggregation of the protein, is also able to modulate binding inter-
actions. Measurements of intrachain dynamics indicate that modifications alter
the flexibility of the C-terminus as well as the conformational ensemble popu-
lated by the protein. The second protein, tau, is a microtubule binding protein
that is found in aggregated paired-helical filaments in Alzheimer’s and other
